These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 26121437)
1. NORMOMAGNESEMIC GITELMAN SYNDROME PATIENTS EXHIBIT A STRONGER REACTION TO THIAZIDE THAN HYPOMAGNESEMIC PATIENTS. Jiang L; Peng X; Ma J; Yuan T; Qin Y; Wang O; Wang H; Wang Y; Chen G; Yue C; Li C; Nie M; Xing X; Li X; Lee X; Chen L Endocr Pract; 2015 Sep; 21(9):1017-25. PubMed ID: 26121437 [TBL] [Abstract][Full Text] [Related]
2. Clinical severity of Gitelman syndrome determined by serum magnesium. Jiang L; Chen C; Yuan T; Qin Y; Hu M; Li X; Xing X; Lee X; Nie M; Chen L Am J Nephrol; 2014; 39(4):357-66. PubMed ID: 24776766 [TBL] [Abstract][Full Text] [Related]
3. Value of Chloride Clearance Test in Differential Diagnosis of Gitelman Syndrome. Peng XY; Jiang LP; Yuan T; Yue C; Zheng K; Wang O; Li NS; Li W; Tong AL; Xing XP; Li XM; Li XW; Chen LM Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Jun; 38(3):275-82. PubMed ID: 27469911 [TBL] [Abstract][Full Text] [Related]
4. A NOVEL COMPOUND HETEROZYGOUS VARIANT OF SLC12A3 GENE IN A PEDIGREE WITH GITELMAN SYNDROME CO-EXISTENT WITH THYROID DYSFUNCTION. Liu S; Ke J; Zhang B; Yu C; Feng Y; Zhao D Endocr Pract; 2018 Oct; 24(10):889-893. PubMed ID: 30084681 [TBL] [Abstract][Full Text] [Related]
5. Quadriparesis due to Gitelman's syndrome diagnosed with thiazide diuretic test response. Mukhopadhyay S; Jana S; Chatterjee A; Roy M; Sarkar A; Mukhopadhyay J Saudi J Kidney Dis Transpl; 2016 Mar; 27(2):407-10. PubMed ID: 26997401 [TBL] [Abstract][Full Text] [Related]
6. Acquired Gitelman Syndrome in an Anti-SSA Antibody-positive Patient with a SLC12A3 Heterozygous Mutation. Kusuda T; Hosoya T; Mori T; Ihara K; Nishida H; Chiga M; Sohara E; Rai T; Koike R; Uchida S; Kohsaka H Intern Med; 2016; 55(21):3201-3204. PubMed ID: 27803420 [TBL] [Abstract][Full Text] [Related]
7. Gitelman syndrome: consensus and guidance from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Blanchard A; Bockenhauer D; Bolignano D; Calò LA; Cosyns E; Devuyst O; Ellison DH; Karet Frankl FE; Knoers NV; Konrad M; Lin SH; Vargas-Poussou R Kidney Int; 2017 Jan; 91(1):24-33. PubMed ID: 28003083 [TBL] [Abstract][Full Text] [Related]
10. Novel SLC12A3 gene mutations and clinical characteristics in two pedigrees with Gitelman syndrome. Ying Q; Ye Z; Zhang W; Pan Y; Dai L; Lin K; Feng X; Dong X; He F Clin Endocrinol (Oxf); 2023 Nov; 99(5):474-480. PubMed ID: 36562655 [TBL] [Abstract][Full Text] [Related]
11. Case report: Gitelman syndrome with diabetes: Confirmed by both hydrochlorothiazide test and genetic testing. Yang L; Fan J; Liu Y; Ren Y; Liu Z; Fu H; Qi H; Yang J Medicine (Baltimore); 2023 Jun; 102(24):e33959. PubMed ID: 37327293 [TBL] [Abstract][Full Text] [Related]
12. Clinical and laboratory features of female Gitelman syndrome and the pregnancy outcomes in a Chinese cohort. Zhang L; Peng X; Zhao B; Zhu Z; Wang Y; Tian D; Yan Z; Yao L; Liu J; Qiu L; Xing X; Chen L Nephrology (Carlton); 2020 Oct; 25(10):749-757. PubMed ID: 32542819 [TBL] [Abstract][Full Text] [Related]
13. Gitelman syndrome with normocalciuria - a case report. Flisiński M; Skalska E; Mączyńska B; Butt-Hussaim N; Sobczyńska-Tomaszewska A; Haus O; Manitius J BMC Nephrol; 2022 May; 23(1):170. PubMed ID: 35509038 [TBL] [Abstract][Full Text] [Related]
14. Review and Analysis of Two Gitelman Syndrome Pedigrees Complicated with Proteinuria or Hashimoto's Thyroiditis Caused by Compound Heterozygous Zhang JH; Ruan DD; Hu YN; Ruan XL; Zhu YB; Yang X; Wu JB; Lin XF; Luo JW; Tang FQ Biomed Res Int; 2021; 2021():9973161. PubMed ID: 34046503 [TBL] [Abstract][Full Text] [Related]
15. [Expert consensus for the diagnosis and treatment of patients with Gitelman syndrome]. Gitelman Syndrome Collaborative Study Group Zhonghua Nei Ke Za Zhi; 2017 Sep; 56(9):712-716. PubMed ID: 28870047 [TBL] [Abstract][Full Text] [Related]
16. Complicated Gitelman syndrome and autoimmune thyroid disease: a case report with a new homozygous mutation in the SLC12A3 gene and literature review. Zhou H; Liang X; Qing Y; Meng B; Zhou J; Huang S; Lu S; Huang Z; Yang H; Ma Y; Luo Z BMC Endocr Disord; 2018 Nov; 18(1):82. PubMed ID: 30409157 [TBL] [Abstract][Full Text] [Related]
17. Increased urinary prostaglandin E2 metabolite: A potential therapeutic target of Gitelman syndrome. Peng X; Jiang L; Chen C; Qin Y; Yuan T; Wang O; Xing X; Li X; Nie M; Chen L PLoS One; 2017; 12(7):e0180811. PubMed ID: 28700713 [TBL] [Abstract][Full Text] [Related]
18. Reduced urinary excretion of thiazide-sensitive Na-Cl cotransporter in Gitelman syndrome: preliminary data. Joo KW; Lee JW; Jang HR; Heo NJ; Jeon US; Oh YK; Lim CS; Na KY; Kim J; Cheong HI; Han JS Am J Kidney Dis; 2007 Nov; 50(5):765-73. PubMed ID: 17954289 [TBL] [Abstract][Full Text] [Related]
19. Localization of tubular adaptation to renal sodium loss in Gitelman syndrome. Favre GA; Nau V; Kolb I; Vargas-Poussou R; Hannedouche T; Moulin B Clin J Am Soc Nephrol; 2012 Mar; 7(3):472-8. PubMed ID: 22241817 [TBL] [Abstract][Full Text] [Related]
20. Mutations in SLC12A3 and CLCNKB and Their Correlation with Clinical Phenotype in Patients with Gitelman and Gitelman-like Syndrome. Lee JW; Lee J; Heo NJ; Cheong HI; Han JS J Korean Med Sci; 2016 Jan; 31(1):47-54. PubMed ID: 26770037 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]